KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Inventory (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Inventory for 13 consecutive years, with $8.4 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 21.8% to $8.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.4 million through Dec 2025, up 21.8% year-over-year, with the annual reading at $8.4 million for FY2025, 21.8% up from the prior year.
  • Inventory hit $8.4 million in Q4 2025 for ClearPoint Neuro, up from $6.6 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $9.8 million in Q1 2023 to a low of $3.3 million in Q1 2021.
  • Historically, Inventory has averaged $7.0 million across 5 years, with a median of $7.0 million in 2024.
  • Biggest five-year swings in Inventory: surged 110.09% in 2022 and later fell 21.64% in 2025.
  • Year by year, Inventory stood at $4.9 million in 2021, then skyrocketed by 88.4% to $9.3 million in 2022, then decreased by 14.96% to $7.9 million in 2023, then decreased by 13.25% to $6.9 million in 2024, then rose by 21.8% to $8.4 million in 2025.
  • Business Quant data shows Inventory for CLPT at $8.4 million in Q4 2025, $6.6 million in Q3 2025, and $6.3 million in Q2 2025.